Results 131 to 140 of about 3,490 (198)

No major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials. [PDF]

Arthritis Res Ther
Ramiro S, Gaillez C, Kiltz U, Gensler LS, Pisal C, Braun J, Ogdie A.   +6 more
europepmc   +1 more source

The value of EQ-5D-3L and EQ VAS as a patient-reported outcome measure for patients with ankylosing spondylitis in routine healthcare: an evaluation of construct validity and responsiveness based on the Swedish Rheumatology Quality Register. [PDF]

J Patient Rep Outcomes
Degerlund-Maldi K, Regardt M, Nystrand Länsman C, Larsson L, Parodis I, Heintz E.   +5 more
europepmc   +1 more source

Efficacy of acupuncture in the management of ankylosing spondylitis: a systematic review and meta-analysis with insights. [PDF]

Front Neurol
Zhang J, Sun S, Bai R, Yin H, Chen J, Kong W.   +5 more
europepmc   +1 more source

Validation of the Dudley inflammatory bowel symptom questionnaire for assessing gastrointestinal symptom burden in axial spondyloarthritis. [PDF]

Rheumatol Int
Ozoglu M, Temiz Karadag D, Gokcen N, Ozdemir Isik O, Yilmaz H, Cefle A, Yazici A.   +6 more
europepmc   +1 more source

Comparative efficacy of different exercise interventions in patients with ankylosing spondylitis: a systematic review and network meta-analysis. [PDF]

PeerJ
Kong L, Yu C, Wang C, Meng Z.
europepmc   +1 more source

A systematic review and meta-analysis of the effect of acupuncture therapy on the symptoms and immune indicators of ankylosing spondylitis. [PDF]

Front Neurol
Wang Y, Zhu J, Xue F, Liu W.
europepmc   +1 more source

Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitis. [PDF]

RMD Open
Maksymowych WP, Yeshokumar A, Cerullo E, Lambert RGW, Śliwinska-Stańczyk P, Klimiuk P, Kepich R, Pachai C, Zhu M, Liu J, Landis J, Goti V, Greenberg S.   +12 more
europepmc   +1 more source

Clinical efficacy of tofacitinib in active ankylosing spondylitis and dynamic changes in gut microbiota: an exploratory descriptive four-case series with 16S rRNA sequencing analysis. [PDF]

Front Immunol
Wang L, Xie W, Li J, Chen J, Huang Y.
europepmc   +1 more source

Efficacy and safety of Xeligekimab (GR1501) in the treatment of axial Spondyloarthritis: Results from a Phase II clinical trial. [PDF]

Rheumatol Immunol Res
Zeng X, Zhang S, Liu H, Zhao Y, Li X, Jiang Z, Xue Y, Kong N, Sun L, Liu S, Fan X, Hu J, Shen L, Xu D.   +13 more
europepmc   +1 more source

The effectiveness of different exercise mode interventions in improving disease activity in patients with ankylosing spondylitis: a network and dose-dependent meta-analysis. [PDF]

Front Physiol
Ye G, Gao L, Liu C, Huang J, Zheng X, Gao Y, Wang H, Wang H.   +7 more
europepmc   +1 more source